IP Verse

Esketamine For The Treatment Of Depression

Patent No. EP3501542 (titled "Esketamine For The Treatment Of Depression") was filed by Janssen Pharmaceutica on Dec 21, 2018. The application was issued on Jan 28, 2026.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEOct 6, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3501542

JANSSEN PHARMACEUTICA
Application Number
EP18215651A
Filing Date
Dec 21, 2018
Status
Granted And Under Opposition
Dec 26, 2025
Publication Date
Jan 28, 2026
External Links
Slate, Register , Google Patents